Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Canton Strategic Holdings, Inc. (CNTN) vs Innate Pharma S.A. Sponsored ADR (IPHA)

Canton Strategic Holdings, Inc. and Innate Pharma S.A. Sponsored ADR are both Biotechnology companies. Canton Strategic Holdings, Inc. and Innate Pharma S.A. Sponsored ADR are of similar size ($191.2M and $188.8M). Innate Pharma S.A. Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Canton Strategic Holdings, Inc. trades at 13.7×. Canton Strategic Holdings, Inc. has the higher net margin (0.00% vs −99.7%) and the lower return on invested capital (−8.11% vs 0.00%). Across the 10 metrics below, Innate Pharma S.A. Sponsored ADR leads on 6 and Canton Strategic Holdings, Inc. on 4.

Valuation

Metric CNTN IPHA Biotechnology median
P/E 13.67 n/m 7.88
P/S n/m n/m 11.47
P/B 1.23 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 0.12 10.73
Earnings yield 7.31% (68.62%) (28.84%)
Free cash flow yield (3.96%) 0.00% (23.03%)

Profitability

Metric CNTN IPHA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (99.70%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (43.10%) 0.00% (57.72%)
Return on assets (34.60%) 0.00% (49.22%)
Return on invested capital (8.11%) 0.00% 0.00%

Growth

Metric CNTN IPHA Biotechnology median
Revenue growth (TTM) — (4.17%) 5.64%
EPS growth (last fiscal year) 88.10% 6.06% —
Revenue growth, 5-year CAGR — (33.86%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTN IPHA Biotechnology median
Debt to equity 0.00 (0.50) 0.00
Current ratio 15.70 0.60 4.73
Net debt to EBITDA 0.85 0.22 0.96

Dividend

Metric CNTN IPHA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CNTN IPHA Biotechnology median
Market cap 191.23m 188.77m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack